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Abstract
The product subject of this assessment is L-threonine produced by fermentation with a genetically
modiﬁed strain of Escherichia coli (CGMCC 11473). It is intended to be used in feed and water for
drinking for all animal species and categories. It was not possible to characterise the genetic
modiﬁcation with the information provided. Uncertainty remained on the possible presence of cells
from the production strain and their recombinant DNA in the product. Therefore, the EFSA Panel on
Additives and Products or Substances used in Animal Feed (FEEDAP) could not conclude on the safety
of the product L-threonine, produced by fermentation with Escherichia coli CGMCC 11473 for the target
species, consumers and the environment. The FEEDAP Panel has concerns on the safety of the
simultaneous oral administration of threonine containing additives via water for drinking and feed. In
the absence of data, the FEEDAP Panel cannot conclude on the potential of the additive to be an
irritant for skin and eyes or to be a skin sensitiser. There is a risk from the exposure by inhalation to
endotoxins for persons handling the additive. The product under assessment is considered an
efﬁcacious source of the amino acid L-threonine for all animal species. For L-threonine to be as
efﬁcacious in ruminants as in non-ruminant species, it requires protection against degradation in the
rumen.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on L-threonine
produced by fermentation using the genetically modiﬁed strain Escherichia coli CGMCC 11473 for all
animal species.
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-threonine
was in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant EFSA
guidance documents. The FEEDAP Panel used the data provided by the applicant together with data
from other sources, such as previous risk assessments by the European Food Safety Authority (EFSA)
or other expert bodies, peer-reviewed scientiﬁc papers, other scientiﬁc reports and experts’ knowledge,
to deliver the present output.
The characterisation of the genetic modiﬁcation could not be drawn from the information provided.
Uncertainty remained on the possible presence of cells from the production strain and their
recombinant DNA in the product. Therefore, the FEEDAP Panel could not conclude on the safety of the
product L-Threonine, produced by fermentation with Escherichia coli CGMCC 11473 for the target
species, consumers and the environment.
The FEEDAP Panel had concerns on the safety of the simultaneous oral administration of threonine
containing additives via water for drinking and feed.
In the absence of data, the FEEDAP Panel could not conclude on the potential of the additive to be
an irritant for skin and eyes or to be a skin sensitiser. There was a risk from the exposure to
endotoxins by inhalation for persons handling the additive.
The product under assessment was considered an efﬁcacious source of the amino acid L-threonine
for all animal species. For L-threonine to be as efﬁcacious in ruminants as in non-ruminant species, it
requires protection against degradation in the rumen.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Agri Nutrition BV2 for authorisation of the
product L-threonine produced by microbial fermentation with Escherichia coli, when used as a feed
additive for all animal species (category: nutritional additives; functional group: amino acids, their salts
and analogues).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 15 April 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product L-threonine, when used under the proposed conditions of use (see Section 3.1.3).
1.2. Additional information
L-Threonine produced by eight different strains of E. coli (minimum content of 98% on dry matter
basis) is currently authorised as a nutritional feed additive for use in all animal species (Commission
Implementing Regulation (EU) 2016/1220).3 The current application refers to L-threonine produced
using a genetically modiﬁed strain of E. coli.
L-Threonine like other amino acids and other nitrogen compounds is authorised according to
Commission Directive 2006/141/EC for infant formulae and follow-on formulae.4 According to
Commission Directive 2001/15/EC, amino acids such as L-threonine may be added in all dietary foods
for particular nutritional uses including foods for particular nutritional uses intended for special medical
purposes.5 L-Threonine is also registered as an ingredient in cosmetic products as antistatic, hair
conditioning, hair waiving or straightening (Commission decision 2006/257/EEC). L-Threonine is
registered as pharmaceutical grade (for total parenteral nutrition) in many European countries and is
described in a monograph of the European Pharmacopoeia (MG 01/2008:1049). According to
Commission Regulation (EEC) 2377/90, L-threonine is also listed as pharmacologically active substance
in veterinary medicinal products and is not subjected to maximum residue levels when used in food
producing animals.6
The Scientiﬁc Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) issued
nine opinions on the safety and efﬁcacy of L-threonine produced by genetically modiﬁed strains of
E. coli (EFSA FEEDAP Panel, 2013, 2014a–d, 2015a,b, 2016a,b).
The Scientiﬁc Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with
Food (AFC) issued two opinions related to threonine in the frame of the Flavouring Group Evaluation
26: amino acids from chemical group 34 (EFSA AFC Panel, 2006; EFSA, 2008a).
The Joint FAO/WHO Expert Committee on Food Additives evaluated L-threonine as food ﬂavouring
agent (JECFA, 2012).
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Agri Nutrition BV, Hanzestraat 1, 7006 RH, Doetinchem, The Netherlands.
3 Commission implementing regulation (EU) 2016/1220 of 26 July 2016 concerning the authorisation of L-threonine produced by
Escherichia coli as feed additive for all animal species. OJ L 201, 27.7.2016, p. 5.
4 Commission Directive 2006/141/EC on infant formulae and follow-on formulae, OJ L 401, 30.12.2006, p 1.
5 Commission Directive 2001/15/EC of 15 February 2001 on substances that may be added for speciﬁc nutritional purposes in
foods for particular nutritional uses. OJ L/52, 22.2.2001, p. 19.
6 Commission Regulation (EC) No 1931/1999, amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying
down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of
animal origin. OJ L 240, 10.9.1999, p. 3.
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2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier7 in support of the authorisation request for the use of L-threonine as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20088 and the applicable EFSA guidance documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies, peer-reviewed scientiﬁc papers,
other scientiﬁc reports and experts’ knowledge, to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the L-threonine in animal feed. The Executive Summary of the EURL
report can be found in Annex A.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-threonine is
in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a), Guidance on studies
concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b), Technical
Guidance: Microbial Studies (EFSA, 2008b), Guidance on the assessment of bacterial susceptibility to
antimicrobials of human and veterinary importance (EFSA FEEDAP Panel, 2012c), and Guidance on the
risk assessment of genetically modiﬁed microorganisms and their products intended for food and feed
use (EFSA GMO Panel, 2011).
3. Assessment
The product which is the subject of this application is L-threonine produced by fermentation with
a genetically modiﬁed strain of E. coli. L-Threonine is currently authorised for use as a nutritional
additive, under the functional group ‘amino acids, their salts and analogues’. The product under
application is intended to be used in feed and water for drinking for all animal species and
categories.
The objective of feed supplementation with essential amino acids is to complete the amino acid
proﬁle of the diet in order to closely meet individual amino acid requirements of animals or to
compensate for potential imbalances. The supplementation of feedingstuffs with amino acids is a
conventional measure for improving protein quality and utilisation. This supplementation became
even more important when protein-reduced diets were introduced in animal husbandry for economic
and environmental reasons. L-Threonine is well recognised as an essential amino acid in animal
nutrition. Under European Union (EU) conditions, L-threonine seems to be the second most limiting
amino acid, after L-lysine, in pigs and the third most limiting, after the sulfur amino acids and
L-lysine, in poultry.
3.1. Characterisation
3.1.1. Characterisation of the active substance/additive
L-Threonine (International Union of Pure and Applied Chemistry name: (2S,3R)-2-amino-3-
hydroxybutanoic acid; synonyms: 2-amino-3-hydroxybutyric acid, a-amino-b-hydroxybutyric acid), a
compound identiﬁed with the Chemical Abstracts Service No 72-19-5 and the European Inventory of
Existing Commercial Chemical Substances No 200-774-1, has a molecular mass of 119.12 Da. The
molecular formula of L-threonine is C4H9NO3. The structural formula is given in Figure 1.
7 FEED dossier reference: FAD-2016-0003.
8 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep_fad2016_0003_l_threonine.pdf
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The additive contains, by speciﬁcation, ≥ 98.5% L-threonine, < 1% moisture and < 1.4% other
substances.10 The analysis of ﬁve batches of the additive showed an average of L-threonine of 99.1%
‘as is’ (range 98.3–99.5%).11 The loss on drying was not provided. The amount of unidentiﬁed
material was in average < 1% on a dry matter basis.
The speciﬁc optical rotation was measured in three batches of the ﬁnal product and the average
was 28.1° (range 28.3 to 27.7°),12 which is within the range established for L-threonine in the
European Pharmacopoeia (29.0 to 27.6°) and demonstrates the identity of the L-enantiomer.
3.1.2. Impurities
Five batches were analysed for heavy metals (cadmium, mercury and lead) and were found under
the limit of detection (LOD).13 Arsenic was analysed in other ﬁve batches (average 1.1 mg/kg, range
0.1–4.6 mg/kg).14 None of these amounts were considered of concern.
The microbiological quality of three batches of the product was tested by counting
Enterobacteriaceae (negative), E. coli (negative) and Salmonella spp. (negative in 25 g);15 ﬁlamentous
fungi and yeasts (< 10 colony forming units (CFU)/g).16 Regarding mycotoxins (ochratoxin A, aﬂatoxins
(unspeciﬁed), zearalenone, fumonisin, deoxynivalenol and citrinin),17 all values were below the limit of
quantiﬁcation (LOQ) (except deoxynivalenol which was ≤ 178 lg/kg and citrinin, which was ≤ 31 lg/kg)
and are considered to be of no concern.
Dioxins and dioxin-like polychlorinated biphenyls (PCBs) were measured in three batches of the
ﬁnal product.18 The sum of polychlorinated dibenzofurans (PCDF), polychlorinated dibenzo(p)dioxins
(PCDD) and dioxin-like PCB ranged from 0.13 to 0.14 WHO-TEQ (ng/kg DM).
One batch of the additive was tested for inhibitory activity against the list of reference strains of the
EFSA Guidance on microbial studies (EFSA, 2008a,b).19 For all strains, the minimum inhibitory
concentration values (MIC) were > 2,500 mg/L. The MICs were in all cases greater than four times the
normal use level of the additive in feed, and therefore, the additive is considered not to have
antimicrobial activity at feed use level.
Bacterial endotoxin activities were measured (Limulus Amoebocyte Lysate assay) in three batches
of the ﬁnal product and ranged from 288 to 319 IU/mg.20
No data were provided on the possible presence of viable cells of the production strain in the
product. The applicant states that E. coli was not found in three batches of product (absence in 25 g);
however, the methodology is not described. Test reports were provided in which DNA of the E. coli 16S
rRNA gene was not found by PCR in one batch.21 However, no information was provided on the
amount of samples tested, and no details on the sensitivity of the method were provided. Therefore,
uncertainty remains on the possible presence of the production strain and its DNA in the product.
Figure 1: Molecular structure of L-threonine
10 Technical dossier/Section II.2.1.3.
11 Technical dossier/Section II/Annex 2.1.4a and Supplementary information January 2017/Annex 3. Analytical method in
compliance with EU ofﬁcial method (EC) 152/2009.
12 Technical dossier/Section II/Annex 2.1.3a and supplementary information January 2017/Answers to SIn 270516 revised
version 161210.
13 Technical dossier/Supplementary information January 2017/Annex 6. LOD (in mg/kg) was 5 for lead, 0.5 for cadmium and
0.01 for mercury.
14 Technical dossier/Section II/Annex 2.1.3a.
15 Technical dossier/Section II/Annex 2.1.4a.
16 Technical dossier/Section II/Annex 2.1.3a and supplementary information January 2017/Annex 7. LOQ was < 10 CFU/g.
17 Technical dossier/Section II/Annex 2.1.4a. LOQ (in lg/kg) was 5 for ochratoxin A, 1.7 for aﬂatoxins, 17 for zearalenone, 25 for
fumonisin, 134 for deoxynivalenol and 15 for citrinin.
18 Technical dossier/Supplementary information January 2017/Annexes 8a to 8c.
19 Technical dossier/Section II/Annex 2.2.2.2 and Supplementary information January 2017/Annex 9.
20 Technical dossier/Supplementary information January 2017/Annexes 10a and 10b.
21 Technical dossier/Section II/Supplementary information January 2017/Annexes 12.4 to 12.6.
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3.1.3. Physical characteristics
The particle size distribution of the ﬁnal product (three batches) was analysed by laser diffraction.22
The fractions of particles having a diameter < 100, < 50 and < 10 lm were 85%, 52% and 5% (v/v),
respectively.
Analytical data on the dusting potential (three batches) of the ﬁnal product (Stauber–Heubach
method) ranged from 0.1 to 0.2 g/m3.23
3.1.4. Characterisation of the production organism24
The additive under assessment is produced by a genetically modiﬁed strain of E. coli K-12, which
has been deposited in the China General Microbiological Culture Collection Center (CGMCC) with the
accession number CGMCC 11473.25 The strain was identiﬁed as an E. coli K-12 derivative by whole
genome sequence (WGS) analysis.26
A non-identiﬁed strain of E. coli K-12 was tested for antimicrobial susceptibility using agar diffusion
against a battery of 12 antimicrobials. Out of the 10 clinically relevant antimicrobials recommended by
EFSA (EFSA FEEDAP Panel, 2012c),27 only ﬁve (gentamycin, tetracycline, ampicillin, kanamycin and
chloramphenicol) were included in the battery. Of those, the MIC values were equal or below the
corresponding cut-off values deﬁned by the FEEDAP Panel, except for kanamycin, which was 256 mg/L.
No information was provided on the genetic basis of this kanamycin resistance. The relationship
between the tested strain and the production strain was not clariﬁed. The genome of the production
strain was not searched for genes conferring resistance to kanamycin or other antimicrobials. Therefore,
uncertainty remains on the possible presence of antimicrobial resistance genes in the production strain.
3.1.4.1. Information relating to the genetically modiﬁed microorganism
No information on the parental or recipient strain was submitted.
3.1.4.2. Description of the genetic modiﬁcation
No information was provided on the changes introduced in the production strain. The WGS of the
production strain was compared to the genome of one of the publicly available genomes of E. coli
K-12, which was used as a reference genome.28 However, the reported analysis of the sequence and
its interpretation were unclear, difﬁcult to interpret and contained some contradictory statements. No
characterisation of the genetic modiﬁcation can be drawn from the report provided.
3.1.4.3. Information related to the production process
L-Threonine is produced by fermentation using E. coli CGMCC 11473. After fermentation, the
fermentation broth is inactivated and separated. L-Threonine is concentrated, puriﬁed, and crystallised.
According to the applicant, no antimicrobial substances are used during the production process.29
3.1.5. Stability and homogeneity
The shelf life of three batches of the product was tested at 25 and 40°C for 12 and 6 months,
respectively.30 The samples were kept in sealed bags protected from light during the storage period.
Losses around 2% were observed at 25°C and around 1% at 40°C.
The stability of the product (three batches) in a vitamin/mineral premixture (containing 18.4 g
choline chloride/kg) supplemented with 10% threonine was studied when stored in closed plastic bags
at room temperature for 6 months.31 Losses observed ranged from 0% (two batches) to 6%.
22 Technical dossier/Section II/Annexes 2.1.5a, 2.1.5b and 2.1.5c.
23 Technical dossier/Section II/Annexes 2.4.3a, 2.4.3b and 2.4.3c.
24 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
25 Technical dossier/Section II/Annexes 2.2.1.2a and 2.2.1.2b.
26 Technical dossier/Section II/ Supplementary information January 2017/Annex 13.4.
27 Technical dossier/Supplementary information January 2017/Annex 12.1.
28 Technical dossier/Section II/ Supplementary information January 2017/Annex 13.4 and annex I.11.
29 Technical dossier/Supplementary information January 2017/Annex 2.
30 Technical dossier/Section II.2.4.1 and Annex 2.1.4a and Supplementary information January 2017/Annexes 3 and 16.
31 Technical dossier/Section II.2.4.1 and Annexes 2.1.4a and 2.4.1; Supplementary information January 2017/Response to Q16
and Annexes 3 and 16.
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The stability of the product (three batches) was tested in a compound feed for piglets (mash and
pelleted feed) when supplemented at 0.5% threonine.32 The basal diet consisted in barley, wheat and
soybean. Pelleting was performed at 65°C. The effect of pelleting represents a loss of 1–4%. The
packaging and temperature conditions during storage were not described. After 3 months storage, a
loss of 6% was observed in only one batch of meal and losses in pelleted feed ranged from 0% to
1%. As total threonine (protein-bound plus free threonine) was analysed instead of supplemental
threonine, the results of this stability study might not reﬂect the real stability of the additive in
feedingstuffs.
The capacity of the additive to distribute homogeneously in feed was tested in 10 samples of a
pelleted feed supplemented at 0.5%.30 The coefﬁcient of variation was 1.5%. Total threonine
(protein-bound plus free threonine) was analysed. Consequently, the result obtained might not reﬂect
the real capacity of the additive to distribute homogeneously in feedingstuffs.
The stability of the product (three batches) in water was tested at a concentration of 5 g/L at room
temperature for 24 h. The losses observed ranged from 0.4% to 2%.33 The FEEDAP Panel notes that
the concentration tested does not represent the practical use (concentrations about one-third of the
usual supplemental level in feed are recommended for additives to be used in water for drinking) and
that the storage period was shorter than the 48 h required in the corresponding guidance.34
3.1.6. Physicochemical incompatibilities in feed
No physicochemical incompatibilities in feed are expected with other additives, medicinal products
or feed materials.
3.1.7. Conditions of use
It is proposed that L-threonine will be used in feeds to achieve an adequate amino acid proﬁle and
to meet the L-threonine requirements for all animal species. It can be added directly to feedingstuffs or
complementary feedingstuffs, or via a premixture. It is also proposed to use the additive in water for
drinking. No inclusion levels have been proposed, as the requirements, in quantitative terms, depend
on the species, the physiological state of the animal, the performance level, the environmental
conditions and the amino acid composition of the unsupplemented diet.
3.2. Safety
3.2.1. Safety aspects of the genetic modiﬁcation
The production strain is resistant to kanamycin, but the genetic basis for this resistance remains
unknown. Potential resistance to ﬁve out of the 10 clinically relevant antimicrobials of those
recommended by EFSA for E. coli is unknown. No characterisation of the genetic modiﬁcation can be
drawn from the information provided. Uncertainty remains on the genetic elements introduced and
deleted, including possible genes conferring resistance to antimicrobials.
Uncertainty remains on the possible presence of cells from the production strain and their
recombinant DNA in the product. Therefore, the FEEDAP Panel cannot conclude on the safety of the
product L-threonine, produced by fermentation with E. coli CGMCC 11473, with regard to the genetic
modiﬁcation of the production strain.
3.2.2. Safety for the target species
Tolerance studies with essential amino acids, such as L-threonine, cannot be designed in accordance
with the protocols of conventional toxicity experiments because high dietary concentrations of a
certain amino acid will result in amino acid imbalances and depression of feed intake and, hence,
impaired performance. Nevertheless, in the case of nutritional additives produced by fermentation, the
risks associated with the residues of the fermentation process in the ﬁnal product need to be assessed.
In this speciﬁc product, the active substance represents > 99% of the additive on a dry matter basis.
The level of endotoxins in the product (288–319 IU/mg) is similar to that observed in other
feedingstuffs and is therefore of no concern for the target species (Cort et al., 1990). The data
32 Technical dossier/Section II.2.4.1 and Annexes 2.1.4a and 2.4.1; Supplementary information January 2017/Annexes 3 and 16.
33 Technical dossier/Section II.2.4.1 and Annex 2.1.4a.
34 Guidance for the preparation of dossiers for nutritional additives. EFSA Journal 2012;10(1):2535.
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submitted cannot exclude the presence of recombinant DNA and antibiotic resistance genes in the ﬁnal
product. Therefore, the FEEDAP Panel cannot conclude on the safety of L-threonine produced by E. coli
CGMCC 11473 for the target species.
The requirements and the effects of excess L-threonine in the diet have already been described in a
previous opinion (EFSA FEEDAP Panel, 2014a). In that opinion, the FEEDAP Panel concluded that feed
supplementation with the amino acid L-threonine, to compensate for threonine deﬁciency in
feedingstuffs, is safe for the target animals. The margin of safety is higher in pigs than in poultry.
Excess doses, however, would create amino acid imbalances with negative consequences on animal
performance. Correct dosing when formulating diets requires knowledge of the amino acid content in
feed materials and the requirement of animals. The FEEDAP Panel considers that the same conclusions
would apply to the active substance L-threonine.
The FEEDAP Panel, in its previous statement (EFSA FEEDAP Panel, 2010), identiﬁed risks of
nutritional imbalances and hygienic concerns in amino acids when administered in water for drinking.
3.2.2.1. Conclusions on safety for the target species
The possible presence in the ﬁnal product of the viable production strain and its recombinant DNA
and/or antibiotic resistance genes cannot be excluded. Therefore, the FEEDAP Panel cannot conclude
on the safety of L-threonine produced by E. coli CGMCC 11473 for the target species.
In addition, the FEEDAP Panel has concerns regarding the safety of the simultaneous administration
of L-threonine via water for drinking and feed.
3.2.3. Safety for the consumer
The absorption, distribution, metabolism and excretion of L-threonine were described in a previous
scientiﬁc opinion of the FEEDAP Panel (EFSA FEEDAP Panel, 2013). The use of 99% pure amino acid
L-threonine in animal nutrition, to meet the animal requirements, does not give rise to concerns for the
safety of the consumer.
The product under assessment, however, is produced by fermentation. The concerns for the
consumer would not derive from the amino acid itself, which will be incorporated into the proteins of
the animal tissues/products, but from the possible residues from the fermentation process. The
possible presence in the ﬁnal product of the viable production strain and its recombinant DNA and/or
antibiotic resistance genes cannot be excluded. Therefore, the FEEDAP Panel cannot conclude on the
safety of L-threonine produced by E. coli CGMCC 11473 for the consumer.
3.2.4. Safety for the user
No studies were submitted to support the safety for the user.
3.2.4.1. Effects on the respiratory system
Dusting potential was measured in three batches and ranged 0.1–0.2 g/m3. The percentage of
particles with diameters < 10, < 50 and <100 lm were 5%, 52% and 85% (v/v, three batches),
respectively. Therefore, workers may be exposed by inhalation.
Users can suffer from occupational respiratory disease depending on the level of endotoxins in air
and dust (Rylander, 1999; Thorn, 2001). The bacterial endotoxin activity (analysed in three batches)
ranged from 288 to 319 IU/mg.
The scenario used to estimate the exposure of persons handling the additive to endotoxins in the
dust, based on the EFSA guidance on user safety (EFSA FEEDAP Panel, 2012b), is described in
Appendix A. The threshold for the quantity of inhaled endotoxins per working day is 900 IU, derived
from the provisional occupational exposure limits given by the Dutch Expert Committee on
Occupational Safety (Health Council of the Netherlands, 2010) and the UK Health and Safety Executive
(HSE, 2013). Based upon calculations of the content of endotoxins in dust, exposure would be
35,444 IU per eight-hour working day, indicating a risk by inhalation due to exposure to endotoxins for
people handling the additive.
3.2.4.2. Conclusions on safety for the user
In the absence of data, the FEEDAP Panel cannot conclude on the potential of the additive to be
irritant to skin and eyes or to be a skin sensitiser. There is a risk from the inhalation exposure to
endotoxins for persons handling the additive.
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3.2.5. Safety for the environment
The amino acid L-threonine is a physiological and natural component of the proteins of living
organisms. When consumed, it will be absorbed, and the non-absorbed fraction will be incorporated
into the intestinal microbial mass and excreted as such. The absorbed L-threonine will be incorporated
into body protein or excreted as urea/uric acid and as carbon dioxide.
Uncertainty remains, however, on the possible presence of genes conferring antimicrobial resistance
in the genome of the production strain, and on the possible presence of cells from the production
strain and their DNA in the product. Therefore, the FEEDAP Panel cannot conclude on the
environmental safety of the product L-threonine, produced by fermentation with E. coli CGMCC 11473,
with regard to the genetic modiﬁcation of the production strain.
3.3. Efﬁcacy
Efﬁcacy studies are not required for amino acids which naturally occur in the proteins of plants and
animals. The nutritional role of L-threonine is well established in the scientiﬁc literature. Since most of
the studies have been performed with supplemental L-threonine, the product L-threonine, technically
pure, is regarded as an effective source of the amino acid L-threonine.
The efﬁcacy of L-threonine for both non-ruminant and ruminant species was described in previous
opinions (EFSA FEEDAP Panel, 2013, 2014a). Supplemental L-threonine is degraded by ruminal
microbiota if not given in a protected form.
The product is considered an efﬁcacious source of the amino acid L-threonine for all animal species.
For the supplemental L-threonine to be as efﬁcacious in ruminants as in non-ruminant species, it must
be protected against degradation in the rumen.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation35 and Good
Manufacturing Practice.
4. Conclusions
The genetic modiﬁcation cannot be assessed. Uncertainty remains on the possible presence of cells
from the production strain and/or their recombinant DNA in the product, including possible genes
conferring antimicrobial resistance. Therefore, the FEEDAP Panel cannot conclude on the safety of the
product L-threonine, produced by fermentation with E. coli CGMCC 11473 for the target species,
consumers and the environment.
The FEEDAP Panel has concerns on the safety of the simultaneous oral administration of
threonine-containing additives via water for drinking and feed.
In the absence of data, the FEEDAP Panel cannot conclude on the potential of the additive to be
irritant to skin and eyes or to be a skin sensitiser. There is a risk from the exposure to endotoxins for
persons handling the additive.
The product under assessment is considered an efﬁcacious source of the amino acid L-threonine for
all animal species. For L-threonine to be as efﬁcacious in ruminants as in non-ruminant species, it
requires protection against degradation in the rumen.
Documentation provided to EFSA
1) Dossier L-threonine produced by Escherichia coli CGMCC 11473. January 2016. Submitted by
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4) Comments from Member States.
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Abbreviations
AFC Scientiﬁc Panel on Food Additives, Flavourings, Processing Aids and Materials in
contact with Food
CFU colony forming units
CGMCC China general microbiological culture collection centre
EURL European Union Reference Laboratory
FEEDAP EFSA scientiﬁc Panel on additives and products or substances used in animal feed
GM genetically modiﬁed
GMO EFSA scientiﬁc Panel on genetically modiﬁed microorganisms
HSE British health safety Executive
IU International unit of endotoxin activity. One IU corresponds to one endotoxin unit (EU)
JECFA Joint FAO/WHO Expert Committee on Food Additives
LOD limit of detection
LOQ limit of quantiﬁcation
MIC minimum inhibitory concentration
PCB polychlorinated biphenyl
PCDD polychlorinated dibenzo(p)dioxins
PCDF polychlorinated dibenzofurans
PCR polymerase chain reaction
WGS whole genome sequence
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Appendix A – Safety for the user
The effects of the endotoxin inhalation and the exposure limits have been described in a previous
opinion (EFSA FEEDAP Panel, 2015a).
Calculation of maximum acceptable levels of exposure from feed additives
The likely exposure time according to EFSA guidance (EFSA FEEDAP Panel, 2012b) for additives
added in premixtures assumes a maximum of 40 periods of exposure per day, each comprising 20 s,
equal to = 800 s per day. With an uncertainty factor of 2, maximum inhalation exposure would occur
for 2 9 800 = 1,600 s (0.444 h per day). Again, assuming a respiration volume of 1.25 m3/h, the
inhalation volume providing exposure to potentially endotoxin-containing dust would be
0.444 9 1.25 = 0.556 m3 per day. This volume should contain no more than 900 IU endotoxin, so the
dust formed from the product should contain no more than 900/0.556 = 1,619 IU/m3.
Calculation of endotoxin content of dust
Two key measurements are required to evaluate the potential respiratory hazard associated with
endotoxin content of the product [the dusting potential of the product, expressed in g/m3; the
endotoxin activity of the dust, determined by the Limulus amoebocyte lysate assay (expressed in
IU/g)]. If data for the dust are not available, the content of endotoxins of the product can be used
instead. If the content of endotoxins of the relevant additive is a IU/g and the dusting potential is
b g/m3, then the content of endotoxins of the dust, c IU/m3, is obtained by the simple multiplication
a 9 b. This resulting value is further used for calculation of potential inhalatory exposure by users to
endotoxin from the additive under assessment (Table A.1) (EFSA FEEDAP Panel, 2012b).
Table A.1: Estimation of user exposure to endotoxins from the additive L-threonine produced by
Escherichia coli CGMCC 11473, including consideration of using ﬁlter half mask (FF P2 or
FF P3)(a) as a preventative measure
Calculation Identiﬁer Description Amount Source
a Endotoxin content IU/g product 319,000 Technical dossier
b Dusting potential (g/m3) 0.2 Technical dossier
a 9 b c Endotoxin content in the air (IU/m3) 63,800
d No of premixture batches made/working day 40 EFSA FEEDAP
Panel (2012b)
e Time of exposure (s)/production of one batch 20 EFSA FEEDAP
Panel (2012b)
d 9 e f Total duration of daily exposure/worker (s) 800
g Uncertainty factor 2 EFSA FEEDAP
Panel (2012b)
f 9 g h Reﬁned total duration of daily exposure (s) 1,600
h/3 600 i Reﬁned total duration of daily exposure (h) 0.44
j Inhaled air (m3)/eight-hour working day 10 EFSA FEEDAP
Panel (2012b)
j/8 9 i k Inhaled air during exposure (m3) 0.56
c 9 k l Endotoxin inhaled (IU) during exposure/
eight-hour working day
35,444
m Health-based recommended exposure limit of
endotoxin (IU/m3)/eight-hour working day
90 Health Council of
the Netherlands
(2010)
m 9 j n Health-based recommended exposure
limit of total endotoxin exposure (IU)/
eight-hour working day
900
l /10 Endotoxins inhaled (IU)/eight-hour working
day reduced by ﬁlter half mask FF P2
(reduction factor 10)
3,544
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l /20 Endotoxins inhaled (IU)/eight-hour working
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1,772
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Annex A – European Union Reference Laboratory (EURL) evaluation report
on the analytical methods submitted in connection with the application for
authorisation of L-threonine produced by E. coli CGMCC 11473 for all
animal species.
In the current application authorisation is sought under Articles 4(1) for L-threonine, under the
category/functional group 3(c) ‘nutritional additives’/‘amino acids, their salts and analogues’ according
to Annex I of Regulation (EC) No 1831/2003. Authorisation is sought for all animal species. The feed
additive is intended to be mixed either in premixtures or added directly to complete feedingstuffs or
water. The Applicant suggested no minimum or maximum L-threonine concentrations in premixtures
and feedingstuffs.
For the quantiﬁcation of threonine in premixtures and feedingstuffs, the Applicant submitted the
ring-trial validated Community method for amino acids using an amino acid analyser or high-
performance liquid chromatography (HPLC) equipped with ion exchange column (IEC). The method
applies for the determination of free (synthetic and natural) and total (peptide-bound and free) amino
acids. Only performance characteristics for the determination of total threonine are reported: – a
relative standard deviation for repeatability (RSDr) ranging from 1.9% to 4.1%; and – a relative
standard deviation for reproducibility (RSDR) ranging from 3.8% to 11.7%. Based on the performance
characteristics available, the EURL recommends for ofﬁcial control this Community method to quantify
threonine in premixtures and feedingstuffs.
For the quantiﬁcation of L-threonine in the feed additive and water, the Applicant suggested to
apply the above-mentioned Community method speciﬁcally designed for the analysis of premixtures
and feedingstuffs. No experimental data were provided to demonstrate the applicability of this method
to the quantiﬁcation of L-threonine in these two matrices. However, the EURL recommends for ofﬁcial
control, based on previous ‘L-threonine’ reports (e.g. FAD-2013-0028), (i) the ‘L-threonine’ monograph
of the Food Chemical Codex (FCC) for the identiﬁcation of L-threonine in the feed additive, using
infrared absorption together with optical rotation and (ii) the ring-trial validated method (EN ISO
17180:2013) based on IEC coupled with post-column derivatisation and ultraviolet (UV) or ﬂuorescence
detection (FD) for the determination of L-threonine in the feed additive and concentrated premixtures
(more than 10%). Precisions of the order of 1–2% were reported for a commercial product with
threonine content of 96%.
The EURL could not evaluate nor recommend any method for the ofﬁcial control to quantify
L-threonine in water.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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